Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

China · Delayed Price · Currency is CNY

16.06

+0.41 (2.62%)

Jul 22, 2026, 3:04 PM CST

74.38% (1Y)

Market Cap	4.09B +69.9%
Revenue (ttm)	1.10B +3.3%
Net Income	-69.43M
EPS	-0.26
Shares Out	261.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (0.65%)
Ex-Dividend Date	n/a

Volume	17,088,905
Open	15.73
Previous Close	15.65
Day's Range	15.47 - 16.50
52-Week Range	7.67 - 21.98
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 22, 2026

About SHE:300246

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, electrocardiograph, maternal and fetal monitor, defibrillator, multifunctional suspension device, internet of things, and central station; hemodiafiltrat... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1993

Employees 1,335

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300246

Full Company Profile

Financial Performance

In 2025, SHE:300246's revenue was 1.10 billion, an increase of 3.29% compared to the previous year's 1.06 billion. Losses were -69.43 million, -2.82% less than in 2024.

Financial Statements